Join
Live feed
·
PRReleasevia Quantisnow
Twist Bioscience Corporation logo

Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics for Difficult to Treat Diseases

ByQuantisnow·Wall Street's wire, on your screen.
TWST· Twist Bioscience Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TWST (Twist Bioscience Corporation) and more on Quantisnow.